1. Analysis of the Dynamics of Cognitive Impairments and Expression of Caspase Cascade Genes in Preclinical Stages of Parkinsonism Modeled Using α-Synuclein Oligomers.
- Author
-
Gruden MA, Inokenteva VI, Solovieva OA, Mikhailova NP, Ratmirov AM, Sherstnev VV, and Storozheva ZI
- Subjects
- Animals, Mice, Frontal Lobe metabolism, Male, Disease Models, Animal, Parkinsonian Disorders genetics, Parkinsonian Disorders metabolism, Memory, Short-Term drug effects, Caspase 3 genetics, Caspase 3 metabolism, alpha-Synuclein genetics, alpha-Synuclein metabolism, Mice, Inbred C57BL, Cognitive Dysfunction genetics, Cognitive Dysfunction metabolism, Caspase 8 genetics, Caspase 8 metabolism, Caspase 9 genetics, Caspase 9 metabolism, Hippocampus metabolism, Cerebellum metabolism
- Abstract
The behavioral effects of α-synuclein oligomers were studied at various times after its chronic intranasal administration to 75-day-old C57BL/6J mice in comparison with the dynamics of changes in the transcriptional activity of caspases genes (Casp9, Casp8, and Casp3) in the hippocampus, frontal cortex, and cerebellum. The negative effects of α-synuclein oligomers on exploratory activity and short-term memory in the novel object recognition test were most pronounced after 90 days from the end of administration, while after 1 and 270 days, partial compensation of the studied cognitive functions was observed. Analysis of the expression of caspase genes suggests that early compensatory mechanisms are associated with suppression of the effector caspase-3 gene expression along with increased activity of the genes encoding initiator caspases-9 and -8. Late compensation processes are associated with a decrease in the activity of initiator caspases in the frontal cortex and cerebellum., (© 2024. Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF